Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
- PMID: 9267316
Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
Abstract
We compared the diagnostic utility of serum concentrations of human heart-type cytoplasmic fatty acid-binding protein (H-FABPc), myoglobin, and their ratio for the early diagnosis of acute myocardial infarction (AMI) in 104 healthy volunteers and 165 patients at admission within 6 h of the onset of chest pain. The ROC curves of the H-FABPc [0.946, 95% confidence interval (CI) = 0.913-0.979] and myoglobin (0.895, 95% CI = 0.846-0.944) between patients with AMI and healthy volunteers were significantly greater than the area under the ratio of myoglobin to H-FABPc (0.823, 95% CI = 0.765-0.881). In 165 patients, the sensitivity (81.8%, 95% CI = 74.2-89.4%), specificity (86.4%, 95% CI = 78.1-94.6%), and predictive accuracy (83.6%, 95% CI = 78.0-89.3%) of H-FABPc > 12 micrograms/L in diagnosing AMI were significantly higher than those of myoglobin, and were similar to those of the combination of H-FABPc > 12 micrograms/L and the ratio < or = 14. We conclude that H-FABPc is a more sensitive and specific marker than myoglobin for the early diagnosis of AMI, and that their ratio cannot give a clear advantage over the measurement of H-FABPc alone.
Similar articles
-
Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein.Clin Chim Acta. 1997 Jun 27;262(1-2):13-27. doi: 10.1016/s0009-8981(97)06547-9. Clin Chim Acta. 1997. PMID: 9204206 Clinical Trial.
-
Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.Clin Chem Lab Med. 2000 Mar;38(3):231-8. doi: 10.1515/CCLM.2000.034. Clin Chem Lab Med. 2000. PMID: 10905760
-
Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction.Heart Vessels. 1995;10(6):304-9. doi: 10.1007/BF02911388. Heart Vessels. 1995. PMID: 8655467
-
[Heart-type fatty acid-binding protein (H-FABP)].Nihon Rinsho. 1999 Aug;57 Suppl:261-4. Nihon Rinsho. 1999. PMID: 10503416 Review. Japanese. No abstract available.
-
Caveat emptor.Am J Med. 2003 Aug 15;115(3):241-4. doi: 10.1016/s0002-9343(03)00361-9. Am J Med. 2003. PMID: 12935832 Review. No abstract available.
Cited by
-
Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.J Natl Med Assoc. 2006 Jul;98(7):1067-70. J Natl Med Assoc. 2006. PMID: 16895274 Free PMC article.
-
An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome.Clin Biochem Rev. 2012 Feb;33(1):3-11. Clin Biochem Rev. 2012. PMID: 22363093 Free PMC article.
-
Biochemical markers of myocardial injury.Indian J Clin Biochem. 2007 Mar;22(1):10-7. doi: 10.1007/BF02912874. Indian J Clin Biochem. 2007. PMID: 23105645 Free PMC article.
-
Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.Acta Pharmacol Sin. 2018 Jul;39(7):1155-1163. doi: 10.1038/aps.2018.37. Epub 2018 May 17. Acta Pharmacol Sin. 2018. PMID: 29770799 Free PMC article. Review.
-
Recent advances in graphene-based nanobiosensors for salivary biomarker detection.Biosens Bioelectron. 2021 Jan 1;171:112723. doi: 10.1016/j.bios.2020.112723. Epub 2020 Oct 13. Biosens Bioelectron. 2021. PMID: 33096432 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical